ERBB2 and ovarian mucinous adenocarcinoma: GOG 241 highlights the challenges of performing randomized clinical trials in patients with rare histologies (like mucinous ovarian carcinomas) as well as the potential utility of isolated case reports in informing clinical management of patients with rare tumors (in this case ERBB2-amplified mucinous ovarian carcinomas).